Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Melanoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hematologic Neoplasms 1

Interventions

Peripheral Blood Stem Cell Transplantation 41fludarabine phosphate 36Cyclophosphamide 35Mycophenolic Acid 28Whole-Body Irradiation 26Cyclosporine 25Busulfan 24Tacrolimus 21Antilymphocyte Serum 20Filgrastim 17Methotrexate 16Etoposide 15Melphalan 13Methylprednisolone 12Radiotherapy 11Psychiatric Rehabilitation 11Flow Cytometry 11Therapeutics 10Polymerase Chain Reaction 8Rituximab 7Bortezomib 7tanespimycin 6sargramostim 6Vorinostat 6Sirolimus 6Gemcitabine 6Cord Blood Stem Cell Transplantation 6Transplantation 5Thiotepa 5Carboplatin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × Nurse Clinicians × Dermatologic × Clear all
NCT00179764 2019-08-30

Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])

Ann & Robert H Lurie Children's Hospital of Chicago

Phase NA Completed
68 enrolled
DermatologicLymphoidMyeloidOther hematologic neoplasm

Melanoma, Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡